What is the dose of Capsicum?

Dietary exposure estimates often fall around 1–30 mg/day capsaicinoids; one small red chili extract study used Capsifen 200 mg/day providing 4 mg capsaicinoids/day for 28 days; clinical studies vary widely from 2–135 mg. | Food/chili intake, capsaicinoids, capsaicin, and sustained release red chili extract formulations should be tracked separately. | Dietary intake is habitual; small formulation trial lasted 28 days; long term repeated higher dose use needs caution. | Capsaicin/capsaicinoid dose is not comparable across food, extract, topical, intranasal, and supplement forms.

Herb Profile

Capsicum

Capsicum annuum

Capsicum/capsaicinoid evidence is dose dependent and mostly stronger for metabolic/appetite or pain related contexts than cognition.

Last reviewed: July 9, 2026•7 sources citedReport a correctionProfile-wide ·A Strong

Use extra caution — Topical use can cause burning, erythema, coughing, and eye irritation. Details

Evidence: Strong Evidence
Typical onset: Varies by prep
Safety rating: High caution
Best for: Metabolic, Analgesic, Skin Support
Avoid / review if: Broken Or Inflamed Skin For Topical Use, Known Chili/Capsaicin Allergy, Uncontrolled Reflux For Oral Products.

Generated profile category visual

At a glance

From this profile's structured data

Evidence: Grade A
Safety: Topical use can cause burning, erythema, coughing, and eye irritation.
Profile context: metabolic, analgesic, skin-support

Next stepsWhere to go next — guides & comparisons

If you want sharper focus → Focus guides
If you want to browse more herbs → All herbs

Safety

Safety & Cautions

Topical use can cause burning, erythema, coughing, and eye irritation. Avoid mucous membranes, broken skin, occlusive dressings, and immediate hot showers.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

Detailed safety fields

Pregnancy, breastfeeding, and contraindications

Broken Or Inflamed Skin For Topical Use
Known Chili/Capsaicin Allergy
Uncontrolled Reflux For Oral Products.
Additive Skin Irritation With Other Topical Rubs
Oral Products May Theoretically Compound Antihypertensive Or Anticoagulant Regimens
But Clinical Evidence Is Limited.

Full safety note

Topical use can cause burning, erythema, coughing, and eye irritation. Avoid mucous membranes, broken skin, occlusive dressings, and immediate hot showers.

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

147 flagged pairings

Bleeding / anticoagulant risk

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Bleeding / anticoagulant riskCertainty: Theoretical

Data provenance recorded for 147 of 147 pairings in this mechanism group.

+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Moderate Caution

81 flagged pairings

Blood-pressure effects

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Blood-pressure effectsCertainty: Theoretical

Data provenance recorded for 81 of 81 pairings in this mechanism group.

+69 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Evidence

Evidence Summary

Evidence lens

Most useful for practical interpretation when safety context also fits.

StrongStrong Evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mapped — Metabolic Regulation

Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note available — Topical use can cause burning, erythema, coughing, and eye irritation.

This profile cites 7 human studies.

Study design details

Evidence Grade

Grade A: Strong Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match: Randomized controlled trial
Risk of Bias: Low
Consistency: Not assessed

Strongest recorded design is a randomized controlled trial, drawn from 4 recorded studies, 2 in people.

How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong: Multiple RCTs, consistent direction, adequate effect size
Moderate: Some RCTs or consistent observational data in humans
Preliminary / Mixed: Animal or in-vitro only, or conflicting human data
Traditional / Theoretical: Traditional use only; no controlled human trials

Clinical Study Summaries (5)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 5 of 5 studies.

What the evidence actually shows

This table contains 5 structured sources, including 0 human evidence sources; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.

Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned

What would change our conclusion?

Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.

Study	Design	N	Dose	Duration	Population	Outcome	Result & magnitude	Source
Capsicum PubMed indexed authors · 2006 Background	Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review.	—	—	—	—	—	—	PubMed →
Peppers and their constituents against obesity Sirotkin AV et al. · Biol Futur · 2023 Background	Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review.	—	—	—	—	—	—	PubMed →
Capsaicin Chang A et al. · 2026 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →
Estimation of Dietary Capsaicinoid Exposure in Korea and Assessment of Its Health Effects Kwon · Nutrients · 2021 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →
Food-grade red chili extract in overweight subjects Joseph et al. · Journal of Dietary Supplements · 2020 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	Source →

Dosing & Timing

Dose guidance: Dietary exposure estimates often fall around 1–30 mg/day capsaicinoids; one small red chili extract study used Capsifen 200 mg/day providing 4 mg capsaicinoids/day for 28 days; clinical studies vary widely from 2–135 mg. | Food/chili intake, capsaicinoids, capsaicin, and sustained release red chili extract formulations should be tracked separately. | Dietary intake is habitual; small formulation trial lasted 28 days; long term repeated higher dose use needs caution. | Capsaicin/capsaicinoid dose is not comparable across food, extract, topical, intranasal, and supplement forms.

How Capsicum works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Capsicum Works

CompoundTarget / ReceptorMechanismEffect / Outcome

Mechanisms & biological pathways

Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.

Metabolic Regulation

Active Compounds

Key constituents studied in Capsicum, with full pharmacology and safety profiles.

Capsaicin — active compound in Capsicum

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Open the full activity atlasCompare effects, evidence, and safety

Guides that use Capsicum

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Sourcing options

Cayenne Pepper product picks

Recommendation status

Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.

Product form & quality guidelines

When sourcing Capsicum, verify the label for:

Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.

Continue comparing

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Capsicum research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to herbs library Safety checker →

Botanical profile context

How to interpret Capsicum

Capsicum herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first format. Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.

When reviewing Capsicum, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.

For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.